NIB Holdings Limited (ASX: NHF) has experienced a lackluster performance in 2023, with shares losing 4.5% of their value since the beginning of the year. In contrast, the ASX 200 index has shown a positive trend, rising approximately 7% during the same period. Looking ahead to 2024, several factors could influence the performance of NIB shares.
One crucial factor is the overall market performance. If there is a global cut in interest rates, it could potentially boost investor sentiment and drive shares higher. Additionally, premium rate increases in the health insurance industry could impact NIB's share price. Reports suggest that the industry is seeking an average premium rate increase of 6% for the next year, a notable jump from the increases seen in recent years. This analysis reflects the potential influences of broader market trends and the healthcare industry on NIB shares, offering insights into ASX healthcare stocks.
Goldman Sachs, while noting that the 6% rate increase is higher than expected, remains optimistic about NIB shares. The broker has assigned a buy rating and a $8.40 price target, implying a potential upside of 13.5% over the next 12 months. Furthermore, Goldman Sachs anticipates a fully franked 3.9% dividend yield for FY 2024, providing investors with a total potential return of approximately 17.5%.
Another element to consider is the potential impact of changes to the National Disability Insurance Scheme (NDIS). NIB entered the NDIS market in 2022 through the acquisition of plan manager Maple and has expanded its presence in the sector through subsequent acquisitions. However, proposed changes to the NDIS could pose challenges, with a review expected to be released in 2024.
Investors will closely monitor these factors, and the outcome of the NDIS review, to gauge the trajectory of NIB shares in 2024. Despite the headwinds, the positive outlook from Goldman Sachs suggests that the private health insurer has the potential for a more favorable performance in the coming year.